| Multiple plasma biomarkers for risk stratification in patients with heart failure and preserved ejection fraction JA Chirinos, A Orlenko, L Zhao, MD Basso, ME Cvijic, Z Li, TE Spires, ... Journal of the American College of Cardiology 75 (11), 1281-1295, 2020 | 71 | 2020 |
| Model selection for metabolomics: predicting diagnosis of coronary artery disease using automated machine learning A Orlenko, D Kofink, LP Lyytikäinen, K Nikus, P Mishra, P Kuukasjärvi, ... Bioinformatics 36 (6), 1772-1778, 2020 | 35 | 2020 |
| Considerations for automated machine learning in clinical metabolic profiling: Altered homocysteine plasma concentration associated with metformin exposure. A Orlenko, JH Moore, P Orzechowski, RS Olson, J Cairns, PJ Caraballo, ... Pacific Symposium on Biocomputing 2018 23, 460-471, 2018 | 34 | 2018 |
| A comparison of methods for interpreting random forest models of genetic association in the presence of non-additive interactions A Orlenko, JH Moore BioData mining 14 (1), 1-17, 2021 | 13 | 2021 |
| Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children C Diorio, PA Shaw, E Pequignot, A Orlenko, F Chen, R Aplenc, DM Barrett, ... Blood advances 4 (20), 5174-5183, 2020 | 13 | 2020 |
| Selection on metabolic pathway function in the presence of mutation-selection-drift balance leads to rate-limiting steps that are not evolutionarily stable A Orlenko, AI Teufel, PB Chi, DA Liberles Biology direct 11 (1), 1-14, 2016 | 13 | 2016 |
| Metabolomics Insights in Early Childhood Caries LH Heimisdottir, BM Lin, H Cho, A Orlenko, AA Ribeiro, A Simon-Soro, ... Journal of Dental Research, 0022034520982963, 2021 | 12 | 2021 |
| Flux control in glycolysis varies across the tree of life A Orlenko, RA Hermansen, DA Liberles Journal of molecular evolution 82 (2), 146-161, 2016 | 11 | 2016 |
| Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis MK Vidula, A Orlenko, L Zhao, L Salvador, AM Small, E Horton, JB Cohen, ... European Journal of Heart Failure 23 (12), 2021-2032, 2021 | 7 | 2021 |
| Characterizing the roles of changing population size and selection on the evolution of flux control in metabolic pathways A Orlenko, PB Chi, DA Liberles BMC evolutionary biology 17 (1), 1-16, 2017 | 6 | 2017 |
| Pathobiont-mediated spatial structuring enhances biofilm virulence in childhood oral disease H Cho, Z Ren, K Divaris, J Roach, B Lin, C Lin, A Azcarate-Peril, ... | | 2022 |
| PLASMA BIOMARKERS FOR RISK STRATIFICATION OF OUTCOMES IN PATIENTS WITH AORTIC STENOSIS M Vidula, A Orlenko, L Zhao, L Salvador, A Smalll, E Horton, J Cohen, ... Journal of the American College of Cardiology 77 (18_Supplement_1), 1753-1753, 2021 | | 2021 |
| A Targeted Plasma Multi-Marker Approach With Machine Learning for Risk Stratification in HFpEF: The TOPCAT Trial JA Chirinos, A Orlenko, L Zhao, M Basso, ME Cvijic, Z Li, T Spires, ... Circulation 140 (Suppl_1), A14549-A14549, 2019 | | 2019 |
| How Do Pathways Evolve?: Mutation-selection Balance an Co-evolution in Metabolic Pathways A Orlenko University of Wyoming, 2016 | | 2016 |
